$14.51
2.19% today
Nasdaq, Apr 04, 08:16 pm CET
ISIN
US2274831047
Symbol
CCRN

Cross Country Healthcare, Inc. Target price 2025 - Analyst rating & recommendation

Cross Country Healthcare, Inc. Classifications & Recommendation:

Hold
100%

Cross Country Healthcare, Inc. Price Target

Target Price $18.61
Price $14.83
Potential
Number of Estimates 4
4 Analysts have issued a price target Cross Country Healthcare, Inc. 2026 . The average Cross Country Healthcare, Inc. target price is $18.61. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 0 Analysts recommend Cross Country Healthcare, Inc. to buy, 8 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cross Country Healthcare, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Cross Country Healthcare, Inc. stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 1.34 1.24
33.46% 7.42%
EBITDA Margin 1.45% 3.54%
78.44% 144.74%
Net Margin -1.06% 1.06%
132.25% 200.30%

8 Analysts have issued a sales forecast Cross Country Healthcare, Inc. 2025 . The average Cross Country Healthcare, Inc. sales estimate is

$1.2b
Unlock
. This is
7.42% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.3b 5.67%
Unlock
, the lowest is
$1.2b 9.81%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $1.3b 33.46%
2025
$1.2b 7.42%
Unlock
2026
$1.3b 4.97%
Unlock
2027
$1.4b 4.15%
Unlock

8 Analysts have issued an Cross Country Healthcare, Inc. EBITDA forecast 2025. The average Cross Country Healthcare, Inc. EBITDA estimate is

$44.0m
Unlock
. This is
126.54% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$51.7m 165.86%
Unlock
, the lowest is
$38.3m 97.02%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $19.4m 85.66%
2025
$44.0m 126.54%
Unlock
2026
$53.9m 22.32%
Unlock
2027
$56.9m 5.56%
Unlock

EBITDA Margin

2024 1.45% 78.44%
2025
3.54% 144.74%
Unlock
2026
4.12% 16.38%
Unlock
2027
4.18% 1.46%
Unlock

5 Cross Country Healthcare, Inc. Analysts have issued a net profit forecast 2025. The average Cross Country Healthcare, Inc. net profit estimate is

$13.1m
Unlock
. This is
194.67% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$16.6m 219.88%
Unlock
, the lowest is
$11.0m 179.10%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-14.2m 121.46%
2025
$13.1m 192.51%
Unlock
2026
$19.4m 47.49%
Unlock
2027
$19.7m 1.81%
Unlock

Net Margin

2024 -1.06% 132.25%
2025
1.06% 200.30%
Unlock
2026
1.48% 39.62%
Unlock
2027
1.45% 2.03%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.44 0.41
121.46% 193.18%
P/E 36.43
EV/Sales 0.33

5 Analysts have issued a Cross Country Healthcare, Inc. forecast for earnings per share. The average Cross Country Healthcare, Inc. EPS is

$0.41
Unlock
. This is
195.35% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.52 220.93%
Unlock
, the lowest is
$0.34 179.07%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.44 121.46%
2025
$0.41 193.18%
Unlock
2026
$0.60 46.34%
Unlock
2027
$0.61 1.67%
Unlock

P/E ratio

Current -34.20 470.93%
2025
36.43 206.52%
Unlock
2026
24.71 32.17%
Unlock
2027
24.27 1.78%
Unlock

Based on analysts' sales estimates for 2025, the Cross Country Healthcare, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.30 6.25%
2025
0.33 9.53%
Unlock
2026
0.31 4.75%
Unlock
2027
0.30 3.96%
Unlock

P/S ratio

Current 0.36 12.49%
2025
0.39 8.01%
Unlock
2026
0.37 4.73%
Unlock
2027
0.36 4.00%
Unlock

Current Cross Country Healthcare, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Barrington Research
Locked
Locked
Locked Mar 14 2025
JMP Securities
Locked
Locked
Locked Feb 06 2025
Barrington Research
Locked
Locked
Locked Dec 10 2024
Truist Securities
Locked
Locked
Locked Dec 05 2024
Benchmark
Locked
Locked
Locked Nov 07 2024
Truist Securities
Locked
Locked
Locked Oct 21 2024
Analyst Rating Date
Locked
Barrington Research:
Locked
Locked
Mar 14 2025
Locked
JMP Securities:
Locked
Locked
Feb 06 2025
Locked
Barrington Research:
Locked
Locked
Dec 10 2024
Locked
Truist Securities:
Locked
Locked
Dec 05 2024
Locked
Benchmark:
Locked
Locked
Nov 07 2024
Locked
Truist Securities:
Locked
Locked
Oct 21 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today